Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 20 for “"hENT1"”.
-
Towards the structural characterisation of equilibrative nucleoside transporters
… that yields of wild-type human ENT isoform 1 (hENT1) obtained using previously optimised methodologies (expression in Spodoptera frugiperda cells and a two-step IMAC/protease purification) were not amenable to further investigations due to instability and poor yields. Second, I explored …
-
Wirkung einer Gemcitabin-basierten Chemotherapie beim Nebennierenrindenkarzinom und Untersuchung möglicher prädiktiver und prognostischer Marker
… human Equilibrative Nucleosie Transporter 1 (hENT1) untersucht. Keiner der Marker hatte einen prädiktiven Vorhersagewert auf das Ansprechen auf die Gem-basierte Therapie oder das progressionsfreie Überleben nach Beginn der Gem-basierten Therapie. Für die Untersuchung des prognostischen Werts …
-
Immunohistochemistry of superficial urothelial carcinoma - a translational study of potential predictive biomarkers
… undertook to examine relevant biomarkers (hENT1 (SLC29A1), p53, EGFR and Her-2) in UC and normal bladder epithelia and discover whether potential relationships existed between these biomarkers, gemcitabine clinical response and patient characteristics such as age, gender and grade. Method: …
-
Effect of human equilibrative nucleoside transporter 1 (hENT1) and ecto-5' nucleotidase (eN) in adenosine formation by neurons and astrocytes under ischemic conditions.
… with neuronal specific expression of human ENT1 (hENT1) and eN knockout (CD73 KO) astrocytes. The aim of this research was to determine the role of ENT1 and eN in ADO release from ischemic-like conditions in primary cultured neurons, astrocytes or co-cultures. Neurons primarily release …
-
Behavioural effects of enhanced expression of equilibrative nucleoside transporter 1 or knockout of ecto-5’-nucleotidase in mice
… we used mice with expression of human ENT1 (hENT1) and deficiency of CD73, respectively, to address the relative importance of intracellular and extracellular pathways in adenosine regulation. [3H]Nitrobenzylthioinosine binding assays were performed and found increased expression of hENT1 …
-
The Role of the Stroma and CYR61 in Chemoresistance in Pancreatic Cancer
… Human equilibrative nucleoside transporter-1 (hENT1) and human concentrative nucleoside transporter-3 (hCNT3) both have important roles in the cellular uptake of the nucleoside analog gemcitabine. While low expression of hENT1 and hCNT3 has been linked to gemcitabine resistance clinically, …
-
Διερεύνηση του προβλεπτικού και προγνωστικού ρόλου της έκφρασης των γονιδίων BRCA1, RRM1, RRM2, hENT1, dCK και CDA στον προχωρημένο μη μικροκυτταρικό καρκίνο του πνεύμονα
… levels of RRM1, RRM2, CDA, dCK and hENT1 genes -all being involved in the intracellular activity and metabolism of gemcitabine- are potential biomarkers for the drug’s efficacy in advanced-stage NSCLC. At the same time, BRCA1 mRNA expression is a candidate molecular predictor of …
-
Computer-Aided Drug Design and Discovery, Screening and Synthesis of Small Molecule Inhibitors of Nucleoside Transporters
… pharmacophore models were made for hCNT1, hCNT3, hENT1, and hENT4. The hCNT3 and hCNT1 pharmacophore were used to select compounds for biological testing. The NBMPR analogue and dipyridamole analogue hENT1 pharmacophores were compared to each other and to a combined pharmacophore for hENT1. The …
-
Role of equilibrative nucleoside transporters 1 and 2 in the transport and disposition of gemcitabine and its metabolites in cervical carcinoma.
… of these proteins. A characterization of hENT1 and hENT2 in both malignant and normal cervical tissue was undertaken, and while no effect of malignancy was observed on hENT1 protein expression, hENT2 protein was nearly three-fold higher in malignant cervical tissue when compared to normal …
-
I. Synthetic Progress Towards the Total Synthesis of Rhodojaponin III II. Design and Synthesis of Novel ENT Inhibitors
… takes advantage of the co-crystal structure of hENT1 in complex with two known inhibitors, dilazep and NBMPR, to rationally design novel inhibitors with improved potency, selectivity, and pharmacological properties. Herein, the generation of a small library of hENT1 inhibitors with promising …
-
Rapamycin-based macrocyclic library development and Equilibrative Nucleoside Transporter 1 (ENT1) inhibition
… human Equilibrative Nucleoside Transporter 1 (hENT1). We attempted to find the mechanism of action of our lead compound. Despite utilizing multiple complementary techniques to attempt to demonstrate JW95’s direct binding to ENT1, but were not able to reproducibly show direct binding. Encouraged …
-
Individualisierte Therapie beim Pankreaskarzinom
… hatte (Originalarbeit 3). Für die Verwendung von hENT1 als potentiell prädiktiven Markers für eine Gemcitabin-Therapie konnte gezeigt werden, dass die Anwendung des monoklona-len Antikörpers SP120 zu keinen validen Aussagen führt (Originalarbeit 4). Eine weitere Standardisierung von Färbetechniken …
-
Underlying Mechanisms Which Regulate Equilibrative Nucleoside Transporter 1 (ENT1): From Fundamental Forms of Regulation to Unifying Signalling Pathways
… but expression of a glycosylation deficient hENT1 mutant in a human cell line has not been published. I predicted that glycosylation was necessary for proper ENT1 function, and would alter protein abundance at the plasma membrane. Using chloroadenosine transport assays, I showed that N48Q …
-
The effect of bromalin and N-Acetylcysteine (NAC) on chemotherapeutic drug uptake by cancer cells in relation to their mucin and human nucleoside transporter profiles
… survival, and viability. The levels of hENT1/2, hCNT1/3 and MRP5 protein showed no significant reductions following treatment with bromelain, NAC, Gem/bromelain, and Gem/NAC, while BromAc treatments displayed significant reductions in hCNT1/3 protein levels. All transporters increased in …
-
Distribution of nucleoside transporter subtypes in rat brain
… of human brain total RNA indicated that both hENT1 and hENT2 have a wide distribution in human brain. Both probes detected RNA species in every region tested. In general, message for all four nucleoside transporters was seen in rat hippocampus, cerebellum, cerebral cortex, striatum and other …
-
Prognostic factors in periampullary adenocarcinoma. A retrospective study over an 11 year period.
… of human equilibrative nucleoside transporter 1 (hENT1) was a favourable prognostic factor and high expression of deoxycytidine kinase (dCK) indicated sensitivity to chemotherapy. In Paper IV, biomarker studies on the human epidermal growth factor receptors 1-3 (HER1-3) revealed a potential …
-
Flavonoids and Related Compounds as Nucleoside Transporter Inhibitors
… substantial inhibitory activity against hENT1, but had no significant effect on hENT2 or hCNT3.This work has identified a novel class of CNT and ENT nucleoside transporter inhibitors and delineated structural determinants of potency and transporter subtype selectivity.
-
Purine transport in plasmodium falciparum
… nucleoside and nucleobase transporters (hENT1 and hFNT1) rather than the parasite-induced New Permeation Pathways (NPP). The overall rate of purine uptake was observed to be approximately doubled in parasite-infected cells compared to uninfected cells and the rate of adenosine uptake was …
-
Quality management in an investigation of mechanisms of 5-fluorouracil and gemcitabine resistance in colorectal and pancreatic cancers
… human equilibrative nucleoside transporter 1 (hENT1) - and pathway specific proteins – dihydropyrimidine dehydrogenase (DPYD) and thymidine phosphorylase (TP) for 5-FU- and a gemcitabine pathway-specific protein, deoxycytidine kinase (DCK). Thereafter, in a briefer study, the application of the …
-
Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy
… mRNA expression of drug influx transporters (hENT1, hCNT1) and efflux transporters (MRP5) in Gr2000 cells were simultaneously up-regulated. Expression of CDA, RRM1 and RRM2 was up-regulated while that of dCK was down-regulated in Gr2000. Also, protein expression of dCK was found to be hardly …